Columbia Care To Raise $25.2 Million In Bought Deal Financing

Columbia Care (CSE: CCHW) is the latest firm to announce a financing. The company this morning announced that it will be conducting a bought deal financing to raise gross proceeds of $25.2 million in a financing lad by Canaccord Genuity.

The financing will see a total of 2.8 million shares of the issuer sold at a price of $9.00 per share to raise gross proceeds of $25.2 million. No warrant is to be issued in connection with the offering, with the offering expected to be sold primarily to one large institutional investor, however a name was not provided.

An over-allotment option has also been granted by the company, valid until the closing of the offering.

Proceeds from the financing are to be used for working capital and general corporate purposes.

The financing is expected to close February 25, 2021.

Columbia Care last traded at $9.78 on the CSE.


Information for this briefing was found via Sedar and Columbia Care Inc. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Moon River Moly: The Davidson Moly-Copper-Tungsten PEA

Integra: The DeLamar Heap Leach Feasibility Study

Highlander Silver: The Saviour Of Bear Creek Mining

Recommended

Mercado Minerals Launches Two Phase Geophysical Program At Copalito Project

Altamira Gold Drills 6.1 g/t Gold Over 2.3 Metres At Cajueiro Central, Begins Testing Two New Targets

Related News

Cresco Labs Receives Court Approval To Proceed With Columbia Care Acquisition

Cresco Labs (CSE: CL) is inching closer to finalizing its previously announced acquisition of Columbia...

Friday, July 15, 2022, 08:09:23 AM

Columbia Care Acquires Colorado Cannabis Firm For US$42 Million

Columbia Care Inc. (CSE: CCHW) announced last night that it has completed the acquisition of...

Tuesday, November 2, 2021, 10:19:00 AM

Columbia Care: Canaccord Drops Price Target To $13

On November 12th, Columbia Care (NEO: CCHW) reported its third quarter financial results. The company...

Sunday, November 21, 2021, 04:52:00 PM

Cresco Labs: Stifel Slashes Price Target From $30 To $8 Following Poor Q4 Results

On March 23rd, Cresco Labs (CSE: CL) announced its fourth-quarter financial results, which disappointed many...

Friday, March 25, 2022, 03:39:00 PM

US Cannabis: Earnings Preview For The Oncoming Fourth Quarter Results

March is turning out to be a busy month in public cannabis, with many of...

Monday, March 8, 2021, 04:10:00 PM